CH Biotech R&D Co., Ltd. announced CHB resignation of Brent Randall Smith as Natural-person director, effective March 2, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83.8 TWD | +1.45% | -3.46% | +4.10% |
05-21 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
05-21 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.10% | 266M | |
+10.39% | 36.87B | |
-.--% | 11.53B | |
-10.13% | 7.07B | |
+3.63% | 6.61B | |
-5.50% | 5.86B | |
-5.49% | 5.65B | |
-13.12% | 5.42B | |
+36.15% | 5.38B | |
-8.13% | 4.85B |
- Stock Market
- Equities
- 6534 Stock
- News CH Biotech R&D Co., Ltd.
- CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director